20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons

Eunyoung Lee, Sunoh Kim, Kwang Chul Chung, Min Kyung Choo, Dong Hyun Kim, Ghilsoo Nam, Hyewhon Rhim

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Most herbal medicines that are orally administrated have been known to be metabolized before they are absorbed from the gastrointestinal tract. We, therefore, examined the effects of 20(S)-ginsenosides Rb1, Rg1 and Rg3, the three most commonly studied ginsenosides in the central nervous system, and their main metabolites on NMDA receptors using fura-2-based digital imaging and perforated whole-cell patch-clamp techniques. Among the nine ginsenosides tested, 20(S)-ginsenoside Rh2 (20(S)-Rh2) along with 20(S)-ginsenoside Rg3 (20(S)-Rg3) produced the highest inhibitory effect in cultured hippocampal neurons. Although 20(S)-Rg3 and 20(S)-Rh2 selectively targeted NMDA receptors with similar potency, they produced additive effects and seemed to modulate different NMDA receptor regulatory sites. As a competitive antagonist, 20(S)-Rh2 seems to inhibit the receptor via its interaction with polyamine-binding sites, and 20(S)-Rg3 does so using glycine-binding sites. Therefore, these results suggest that the treatment of 20(S)-Rh2, a newly identified active ingredient of ginseng, might be a novel preventive candidate in treating neurodegenerative disorders.

Original languageEnglish
Pages (from-to)69-77
Number of pages9
JournalEuropean Journal of Pharmacology
Volume536
Issue number1-2
DOIs
Publication statusPublished - 2006 Apr 24

Fingerprint

Panax
N-Methyl-D-Aspartate Receptors
Ginsenosides
Neurons
Binding Sites
Herbal Medicine
Fura-2
Polyamines
Patch-Clamp Techniques
Neurodegenerative Diseases
Glycine
Gastrointestinal Tract
Central Nervous System
ginsenoside Rh2
ginsenoside Rg3

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Lee, Eunyoung ; Kim, Sunoh ; Chung, Kwang Chul ; Choo, Min Kyung ; Kim, Dong Hyun ; Nam, Ghilsoo ; Rhim, Hyewhon. / 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. In: European Journal of Pharmacology. 2006 ; Vol. 536, No. 1-2. pp. 69-77.
@article{bf3b622c10f94faf854253fe517137ba,
title = "20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons",
abstract = "Most herbal medicines that are orally administrated have been known to be metabolized before they are absorbed from the gastrointestinal tract. We, therefore, examined the effects of 20(S)-ginsenosides Rb1, Rg1 and Rg3, the three most commonly studied ginsenosides in the central nervous system, and their main metabolites on NMDA receptors using fura-2-based digital imaging and perforated whole-cell patch-clamp techniques. Among the nine ginsenosides tested, 20(S)-ginsenoside Rh2 (20(S)-Rh2) along with 20(S)-ginsenoside Rg3 (20(S)-Rg3) produced the highest inhibitory effect in cultured hippocampal neurons. Although 20(S)-Rg3 and 20(S)-Rh2 selectively targeted NMDA receptors with similar potency, they produced additive effects and seemed to modulate different NMDA receptor regulatory sites. As a competitive antagonist, 20(S)-Rh2 seems to inhibit the receptor via its interaction with polyamine-binding sites, and 20(S)-Rg3 does so using glycine-binding sites. Therefore, these results suggest that the treatment of 20(S)-Rh2, a newly identified active ingredient of ginseng, might be a novel preventive candidate in treating neurodegenerative disorders.",
author = "Eunyoung Lee and Sunoh Kim and Chung, {Kwang Chul} and Choo, {Min Kyung} and Kim, {Dong Hyun} and Ghilsoo Nam and Hyewhon Rhim",
year = "2006",
month = "4",
day = "24",
doi = "10.1016/j.ejphar.2006.02.038",
language = "English",
volume = "536",
pages = "69--77",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-2",

}

20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. / Lee, Eunyoung; Kim, Sunoh; Chung, Kwang Chul; Choo, Min Kyung; Kim, Dong Hyun; Nam, Ghilsoo; Rhim, Hyewhon.

In: European Journal of Pharmacology, Vol. 536, No. 1-2, 24.04.2006, p. 69-77.

Research output: Contribution to journalArticle

TY - JOUR

T1 - 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons

AU - Lee, Eunyoung

AU - Kim, Sunoh

AU - Chung, Kwang Chul

AU - Choo, Min Kyung

AU - Kim, Dong Hyun

AU - Nam, Ghilsoo

AU - Rhim, Hyewhon

PY - 2006/4/24

Y1 - 2006/4/24

N2 - Most herbal medicines that are orally administrated have been known to be metabolized before they are absorbed from the gastrointestinal tract. We, therefore, examined the effects of 20(S)-ginsenosides Rb1, Rg1 and Rg3, the three most commonly studied ginsenosides in the central nervous system, and their main metabolites on NMDA receptors using fura-2-based digital imaging and perforated whole-cell patch-clamp techniques. Among the nine ginsenosides tested, 20(S)-ginsenoside Rh2 (20(S)-Rh2) along with 20(S)-ginsenoside Rg3 (20(S)-Rg3) produced the highest inhibitory effect in cultured hippocampal neurons. Although 20(S)-Rg3 and 20(S)-Rh2 selectively targeted NMDA receptors with similar potency, they produced additive effects and seemed to modulate different NMDA receptor regulatory sites. As a competitive antagonist, 20(S)-Rh2 seems to inhibit the receptor via its interaction with polyamine-binding sites, and 20(S)-Rg3 does so using glycine-binding sites. Therefore, these results suggest that the treatment of 20(S)-Rh2, a newly identified active ingredient of ginseng, might be a novel preventive candidate in treating neurodegenerative disorders.

AB - Most herbal medicines that are orally administrated have been known to be metabolized before they are absorbed from the gastrointestinal tract. We, therefore, examined the effects of 20(S)-ginsenosides Rb1, Rg1 and Rg3, the three most commonly studied ginsenosides in the central nervous system, and their main metabolites on NMDA receptors using fura-2-based digital imaging and perforated whole-cell patch-clamp techniques. Among the nine ginsenosides tested, 20(S)-ginsenoside Rh2 (20(S)-Rh2) along with 20(S)-ginsenoside Rg3 (20(S)-Rg3) produced the highest inhibitory effect in cultured hippocampal neurons. Although 20(S)-Rg3 and 20(S)-Rh2 selectively targeted NMDA receptors with similar potency, they produced additive effects and seemed to modulate different NMDA receptor regulatory sites. As a competitive antagonist, 20(S)-Rh2 seems to inhibit the receptor via its interaction with polyamine-binding sites, and 20(S)-Rg3 does so using glycine-binding sites. Therefore, these results suggest that the treatment of 20(S)-Rh2, a newly identified active ingredient of ginseng, might be a novel preventive candidate in treating neurodegenerative disorders.

UR - http://www.scopus.com/inward/record.url?scp=33645809108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645809108&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2006.02.038

DO - 10.1016/j.ejphar.2006.02.038

M3 - Article

C2 - 16563373

AN - SCOPUS:33645809108

VL - 536

SP - 69

EP - 77

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-2

ER -